Skip to content

Muscle Oxygenation, Type 1 Diabetes, and Glycated Hemoglobin

Impact of Type 1 Diabetes and Glycated Haemoglobin Levels on Oxygen Delivery and Release to Active Muscle During Exercise and on Muscle Oxidation Capacity - Possible Impact on Aerobic Fitness

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02051504
Acronym
OXYDIAB
Enrollment
79
Registered
2014-01-31
Start date
2010-03-31
Completion date
2013-12-31
Last updated
2016-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Keywords

Type 1 diabetes, Glycated hemoglobin, Muscle Oxygenation, Exercise, Maximal Oxygen uptake, Mitochondrial respiration, Endocannabinoid system, Oxidative stress

Brief summary

Most of the studies concerning aerobic fitness in Type 1 diabetic patients noted a relationship between impaired aerobic fitness and high glycated haemoglobin (HbA1c) levels, reflecting poor long term glycaemic control. To explain this relationship, the indirect effect of chronically high blood glucose levels on cardiovascular complications - and hence on exercise cardiovascular adaptations - are often mentioned. However, one could wonder if HbA1c could also have a direct impact on aerobic fitness patients with Type 1 diabetes. Haemoglobin glycation may increase its O2 affinity, thus limiting the O2 availability at the muscular level and impairing maximal aerobic power. Moreover, chronic hyperglycaemia might have deleterious effect on muscle mitochondrial capacity to use O2. The aim of this study is to assess the effect of Type 1 diabetes and of HbA1c level on muscular oxygen delivery and use and hence on aerobic fitness.

Detailed description

The current study aims at assessing the impact of Type 1 diabetes and HbA1c on muscle oxygen delivery and on muscle mitochondrial capacity. Our hypothesis is that these both steps of the oxygen cascade might be involved in the aerobic fitness impairment usually observed in poor-controlled patients. Adults with Type 1 diabetes, aged 18-40 years, without microvascular and macrovascular diabetic complications, will be recruited among patients that regularly attend the unit of diabetology of the University Hospital of Lille and the regional hospital of Roubaix. They will be separated into 2 groups according to their glycaemic control at entrance in the study (HbA1c \< 7%, HbA1c \> 8%). Subsequently, two healthy control groups (checked by an OGTT) will be selected to strictly match the patients with Type 1 diabetes (age, sex, BMI, number of hours of physical activity per week, tobacco smoking). This is a cross-sectional study including 4 groups. On their first visit, after the determination of HbA1c, all the subjects will perform at rest a DLCO/DLNO. Then they will realise an incremental exercise test to exhaustion on an electromagnetic cycle ergometer. Non-invasive measures will be performed throughout the exercise test, including gas exchange parameters (and maximal oxygen uptake), muscular and brain oxygenation (Near Infra Red Spectroscopy at vastus lateralis muscle and at prefrontal cortex). A blood sample from an arterialised ear-lobe will be taken at rest and exhaustion to determine O2 haemoglobin saturation, arterial partial pressure in O2 and CO2, haemoglobin concentration, hematocrit, and bicarbonates. Blood, from a catheter in a superficial cubital vein, will also be taken at rest, at a precise time during the exercise and immediately after the exercise to measure potential of hydrogen, bicarbonates, haemoglobin concentration, hematocrit, erythrocyte 2,3-diphosphoglycerate, and other blood markers of metabolic and hormonal adaptations to exercise. The subjects will also fill in questionnaires. On a second visit, in a fasting state, the subjects will have a muscle biopsy at vastus lateralis using a specific needle (less than 150mg) in order to assess mitochondrial respiration capacity and endocannabinoid system activity. A venous blood sampling will allow analysing other health markers (lipid profile, insulin resistance...). On another visit, the subjects will have a measure of body composition by Dual energy X-ray Absorptiometry and skinfold thickness. They will also wear an accelerometer over one week and fill in a diet questionnaire over 3 days.

Interventions

BEHAVIORALIncremental maximal exercise

The exercise test starts 2-4h after a standardised breakfast. After a 2-min resting period sitting on the cycle ergometer (Excalibur Sport, Lode B.V, Medical Technology, Groningen, Netherlands), the test starts at 30 watts with a 20 watts increment every 2min until exhaustion.

DIETARY_SUPPLEMENTOral Glucose Tolerance Test

The subjects arrive after an overnight fast and have a 75g Glucose Oral Charge.

PROCEDUREMuscle biopsy

A sample of vastus lateralis (less than 150mg) is taken with a specific needle under local anesthesia.

PROCEDURECombined DLCO-DLNO

Lung carbon monoxide and nitric oxide diffusion capacities are assessed at rest in a sitting position.

Body composition is measured using dual energy X-ray absorptiometry at rest.

PROCEDUREAccelerometry over one week

The subjects wear an uniaxial accelerometer over one week to assess their usual physical activity level

OTHERQuestionnaires

Diet questionnaire, quality-of-life questionnaires, physical activity questionnaires

Sponsors

University Hospital, Lille
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with Type 1 diabetes (duration of Type 1 diabetes \> 1 year and \< 20 years) * Healthy subjects

Design outcomes

Primary

MeasureTime frameDescription
Maximal oxygen uptakeParticipants will perform the incremental maximal exercise on visit 1, one week minimum and 8 weeks maximum after their inclusion in the protocolIncremental maximal exercise with gas exchange measure

Secondary

MeasureTime frameDescription
Arterial oxygen content during maximal exercisePrior to the incremental maximal exercise on visit 1, and immediately after the incremental maximal exercise on visit 1.measured in ear-lobe arterialised capillary samples
Oxyhemoglobin dissociation at active muscle during maximal exerciseOn visit 1, continuously during the incremental maximal exerciseDeoxyhemoglobin and total hemoglobin assessed at vastus lateralis by Near Infrared Spectroscopy
Mitochondrial respiration capacity of vastus lateralis muscleParticipants will have a muscle biopsy on visit 2, performed 3 days minimum and 32 weeks maximum after their visit 1.Vastus lateralis muscle sample is obtained by the percutaneous technique after local anesthesia. The mitochondrial respiration is then studied in situ in saponin-skinned fibers.
Prefrontal cortex oxygenation during exerciseOn visit 1, continuously during the incremental maximal exerciseTotal hemoglobin and oxyhemoglobin are assessed at the left prefrontal cortex using Near-Infrared Spectroscopy.

Other

MeasureTime frameDescription
Other factors than hemoglobin glycation that could influence arterial oxygen contentPrior to the incremental maximal exercise on visit 1Lung capillary carbon monoxide and nitric oxide diffusion capacities (DLCO, DLNO)
Body compositionPrior to incremental maximal exercise on visit 1Dual energy X-ray Absorptiometry, skinfold thickness, waist and hip circumferences
Other factors able to modify the oxyhemoglobin dissociation curvePrior to the incremental maximal exercise on visit 1, and immediately after the incremental maximal exercise on visit 1.venous erythrocyte 2,3-diphosphoglycerate, arterialised capillary potential of hydrogen oxygen partial pressure, carbon dioxide partial pressure
Mechanisms possibly involved in muscle mitochondrial dysfunctionsPrior to the incremental maximal exercise on visit 1, and immediately after the incremental maximal exercise on visit 1. Prior to the muscle biopsy on visit 2.oxidative stress (blood oxidative and antioxidant markers at rest and in response to maximal exercise), endocannabinoid system activity
Other health markers in link with physical activity levels and aerobic fitnessPrior to the incremental maximal exercise on visit 1, and immediately after the incremental maximal exercise on visit 1. Prior to the muscle biopsy on visit 2.Lipid profile (HDL-C, LDL-C, apolipoprotein A1, apolipoprotein B, lipoprotein a, ...) Insulin resistance markers (blood ghrelin, adiponectin, leptin...)
Blood metabolic and hormonal responses to exercisePrior to the incremental maximal exercise on visit 1, and immediately after the incremental maximal exercise on visit 1.Free fatty acids, glycerol, glucose, insulin, catecholamines, glucagon, cortisol, insulin-like growth factor 1, brain-derived neurotrophic factor...

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026